Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | S100A1 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | NUP88 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | CST3 | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
mRNA | NUSAP1 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | TRNP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | LTBP3 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | CTC-326K19.6 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | ARID2 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | UBE2N | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
mRNA | GNG12 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-05 |